Every material Form 8-K XFLH Capital Corp has filed with the SEC since February 20, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
XFLH Capital Corporation, a blank check company, entered into a non-binding letter of intent on September 18, 2026 for a proposed business combination with Renogen Biolab Inc., a Canadian health service provider offering DNA services, vector engineering, and protein expression. The parties agreed to negotiate definitive agreements and to give each other access to information for due diligence, but the filing discloses no deal terms, valuation, or closing timeline, and no definitive agreement has been signed.
Letter of intent entered September 18, 2026; announced in a press release dated September 22, 2026
Letter of intent is non-binding; parties will use reasonable best efforts to negotiate definitive agreements
Filing discloses no valuation, consideration, or closing timeline for the proposed combination
If a definitive agreement is signed, the company says it will prepare a proxy statement for stockholders
XFLH Capital Corporation, a blank check company, said holders of its IPO units may separate the ordinary shares and rights starting March 9, 2026. The separated shares and rights will trade on the NYSE under XFLH and XFLHR, while unseparated units continue under XFLHU. This is an administrative trading change and does not report any financial results or a business combination.
Separate trading of ordinary shares (XFLH) and rights (XFLHR) begins March 9, 2026 on the NYSE.
Units not separated continue trading under XFLHU.
Each unit consists of one ordinary share and one right to receive one-seventh of a share upon the initial business combination.
Holders must have their brokers contact transfer agent Continental Stock Transfer & Trust Company to separate units.
XFLH Capital Corporation, a blank check company, completed its initial public offering of 10,000,000 units at $10.00 per unit on February 13, 2026, raising $100,000,000 in gross proceeds. The $100,000,000 from the offering and a related private placement was deposited in a U.S. trust account for public shareholders, and the company has 15 months from the closing to complete a business combination.
10,000,000 units sold at $10.00 each, generating $100,000,000 in gross proceeds on February 13, 2026
Private placement with sponsor XFLH Holdings Limited of 154,970 units, generating $1,549,700
$100,000,000 placed in trust account with Continental Stock Transfer & Trust Company as trustee
Company has 15 months from February 13, 2026 to complete an initial business combination; the 45-day over-allotment option covers up to 1,500,000 additional units
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every XFLH Capital Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →